BWXT Stock Risk & Deep Value Analysis

BWX Technologies Inc

DVR Score

2.0

out of 10

Risk Trap

What You Need to Know About BWXT Stock

We analyzed BWX Technologies Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran BWXT through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Conservative. Here's what we found.

Updated Jun 16, 2026Run Fresh Analysis →

BWXT Risk Analysis & Red Flags

What Could Go Wrong

BWXT's reliance on U.S. government contracts (approx. 60-70% of revenue, primarily U.S. Navy) exposes it to significant regulatory and budgetary risks. A substantial cut to naval programs or failure to renew key long-term contracts (some of which run beyond FY2028) could impact billions in backlog and annual revenue, with limited immediate replacement options.

Risk Matrix

Overall

Conservative

Financial

Low

Market

Low

Competitive

Low

Execution

Low

Regulatory

Medium

Red Flags

  • High dependence on government funding, making up ~60-70% of total revenue, with inherent political and budgetary risks.

  • Long lead times and capital intensity in nuclear projects, tying up capital for years before significant revenue generation.

  • Limited immediate catalysts for exponential (10x) growth from current large-cap valuation given industry maturity.

  • Insider activity limited to minor dividend equivalent rights grant, not signaling significant conviction in near-term outsized returns.

Upcoming Risk Events

  • 📅

    Delay in Government Project Funding (FY2027 budget cycle): Any significant cuts or delays in the U.S. Navy's shipbuilding or nuclear programs could impact ~60-70% of BWXT's revenue, potentially causing a 5-10% revenue decline.

  • 📅

    SMR Regulatory Delays (on-going): Prolonged NRC approval processes or public opposition to SMR deployments could push back revenue generation from this growth segment beyond 2030.

When to Reconsider

  • 🚪

    Exit if core Nuclear Operations segment revenue growth consistently falls below 3% annually for two consecutive quarters.

  • 🚪

    Sell if free cash flow turns negative for two consecutive quarters without a clear, funded path to recovery.

  • 🚪

    Exit if the U.S. government announces a material reduction in naval shipbuilding or nuclear support programs impacting future contracts by >$100M annually.

Unlock BWXT Risk Analysis & Red Flags

Create a free account to see the full analysis

Investment Thesis

If BWXT successfully secures key SMR component contracts (e.g., for ~2-3 new SMR projects by FY2028) and scales medical isotope production (targeting >$100M in new annual revenue by FY2027), then these growth vectors could incrementally accelerate its mid-single-digit revenue growth to high single-digits, justifying a modest re-rating closer to 28-30x P/E. This is bullish because the market currently values BWXT more as a stable defense contractor than a growth-oriented nuclear innovator.

Is BWXT Stock Undervalued?

BWX Technologies maintains an unassailable market position in specialized nuclear technologies (naval propulsion, SMRs, medical isotopes), supported by significant government partnerships and a robust economic moat. However, the mandate for a 10x return within 3-5 years from an already large-cap company ($17.77B) remains exceedingly challenging, consistent with our previous analysis. The nuclear industry is highly capital-intensive, with long development cycles and heavy regulatory oversight, which inherently limits hyper-growth potential. While SMRs and medical isotopes offer long-term growth, they are unlikely to generate the exponential revenue required for such a return within the specified timeframe from the current valuation. No material changes in company fundamentals or market conditions have been observed since the last analysis that would significantly alter this outlook. The recent insider grant of dividend equivalent rights is a minor event and does not signal a shift in 10x potential.

Unlock the full AI analysis for BWXT

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

BWXT Price Targets & Strategy

12-Month Target

$215.00

Bull Case

$240.00

Bear Case

$175.00

Valuation Basis

Based on 25x forward P/E applied to est. FY2026 EPS of $8.60, aligning with historical multiples for defense/specialized industrials.

Entry Strategy

Dollar-cost average on dips towards $185 (recent support) or $190. Buy zone around $180-$190.

Exit Strategy

Take profit at $230-$240. Stop loss at $170 to protect against sector-wide de-rating or significant contract loss.

Portfolio Allocation

2% for moderate risk tolerance, given the stability but limited immediate upside for 10x growth.

Price Targets & Strategy

Sign up free to unlock price targets and entry/exit strategies

Is BWXT Financially Healthy?

Valuation

P/E Ratio

51.85

Forward P/E

49.00

EV/EBITDA

35.30

PEG Ratio

3.34

Price/Book

11.80

Price/Sales

5.50

Profitability

Gross Margin

22.66%

Operating Margin

12.28%

Net Margin

10.20%

Return on Equity

27.91%

Revenue Growth

21.37%

EPS

$3.75

Balance Sheet

Current Ratio

2.32

Quick Ratio

2.25

Debt/Equity

1.64

Total Debt

$2.49B

Cash & Equivalents

$117.00M

Cash Flow

Operating Cash Flow

$522.00M

Free Cash Flow

$328.00M

EBITDA

$545.00M

Other

Beta (Volatility)

0.74

Dividend Yield

0.56%

Does BWXT Have a Competitive Moat?

Sign in to unlock

Moat Rating

🏰 Wide

Moat Trend

Stable

Moat Sources

4 Identified

Intangible Assets/IPSwitching CostsEfficient ScaleGovernment Mandate/Regulation

BWXT's moat is durable due to its unique position as the sole supplier of naval nuclear reactors to the U.S. Navy, coupled with stringent regulatory requirements and the massive capital investment needed to replicate its capabilities. This ensures long-term contractual stability.

Moat Erosion Risks

  • Changes in U.S. defense policy or budget priorities could reduce demand for its core offerings over the very long term.
  • Emergence of new, disruptive nuclear technologies (e.g., fusion) that could bypass BWXT's current expertise (though highly unlikely in 10-20 years).

BWXT Competitive Moat Analysis

Sign up to see competitive advantages

BWXT Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Neutral. BWXT typically has limited retail investor buzz due to its stable, specialized industry profile.

Institutional Sentiment

Neutral to Positive. Analysts generally maintain Buy/Hold ratings reflecting stability, but limited high-conviction upgrades for hyper-growth potential.

Insider Activity (Form 4)

Kenneth J. Krieg, Director, received 30.59 dividend equivalent rights on 2026-06-05, accruing on deferred RSUs. Holds 1,450.81 dividend equivalent rights after this grant. This is not an open market transaction but a routine compensation event and does not signal a change in outlook.

Options Flow

Normal options activity. No significant directional bets or unusual volume observed that would indicate institutional conviction for a 10x move.

Earnings Intelligence

Next Earnings

Estimated early-August 2026 (for Q2 FY2026)

Surprise Probability

Medium. BWXT has a history of meeting or slightly exceeding expectations, but significant surprises are rare given contract-based revenue.

Historical Earnings Pattern

Typically reacts modestly (2-4% moves) to earnings, with significant moves only on major contract wins/losses or substantial guidance revisions.

Key Metrics to Watch

Revenue growth in Nuclear Operations and Nuclear Power segmentsOperating margins, particularly for new contracts or projectsFree cash flow generation and backlog growthUpdates on SMR development milestones and medical isotope production capacity.

Competitive Position

Top Competitor

Huntington Ingalls Industries (HII)

Market Share Trend

Stable. BWXT maintains a dominant, if not monopolistic, position in its core naval nuclear propulsion market, with steady share in related defense segments.

Valuation vs Peers

Trading at a slight premium to defense peers on P/E, justified by specialized niche and stable government contracts, but generally in line on EV/EBITDA.

Competitive Advantages

  • Proprietary technology and expertise in nuclear engineering and manufacturing
  • Deep, long-standing relationships and partnerships with U.S. government (Navy, DOE)
  • High regulatory barriers to entry and certifications required for nuclear operations
  • Cost advantages from scale and specialized infrastructure for nuclear component fabrication.

Market Intelligence

Sign up free to unlock sentiment, earnings intel, and peer analysis

What Could Drive BWXT Stock Higher?

Near-Term (0-6 months)

  • Q2 FY2026 Earnings Report (est. early Aug 2026): Strong guidance for Nuclear Operations segment's profitability and new contract awards could provide a modest boost.
  • Update on B&W's SMR design certification (est. late 2026): A positive regulatory step from the NRC for specific SMR designs could slightly de-risk future deployment, though financial impact is long-term.

Medium-Term (6-18 months)

  • New Naval Reactor Contract Award (est. late 2027-early 2028): Securing a major multi-year contract for submarine or aircraft carrier components, potentially increasing backlog by >$500M.
  • Expansion of Medical Isotope Production (est. FY2027): If new production lines or partnerships significantly scale non-Mo-99 isotope capacity, targeting an additional $50-75M in annual revenue.

Long-Term (18+ months)

  • First Commercial SMR Deployment (if by FY2030): If BWXT's SMR components are integrated into a commercial power plant project, demonstrating tangible revenue from a new growth vector, potentially adding $100M+ annually.
  • Increased U.S. Defense Budget Allocation (post-FY2028): Sustained higher government spending on naval fleet modernization could drive consistent 5%+ annual growth in the core segment.

Catalysts & Growth Drivers

Sign up free to see growth catalysts

What's the Bull Case for BWXT?

  • Watch quarterly SMR component order intake: crossing $25M/quarter would signal meaningful traction in this new segment.

  • Monitor medical isotope revenue growth: sustained >15% QoQ growth indicates successful expansion.

  • Changes in U.S. Navy shipbuilding budget allocations: a significant increase (e.g., >10%) could signal increased long-term backlog.

Bull Case Analysis

Sign up free to see the bull case

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

How BWX Technologies Inc Makes Money

BWX Technologies designs, manufactures, and services nuclear components and provides nuclear fuel, largely for the U.S. government. Its primary business involves supplying nuclear reactors for the U.S. Navy's submarines and aircraft carriers, making it a critical national security partner. The company also develops small modular reactor (SMR) technologies for commercial power generation and produces specialized medical isotopes for cancer treatment. Essentially, BWXT is a highly specialized, technology-driven industrial company focused on the nuclear sector, with the government as its main client.

Read Full Business Model Breakdown

FAQ

What is the DVR Score for BWX Technologies Inc (BWXT)?

As of June 16, 2026, BWX Technologies Inc has a DVR Score of 2.0 out of 10, placing it in the "Risk Trap" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of BWX Technologies Inc?

BWX Technologies Inc's market capitalization is approximately $17.9B..

What is the risk level for BWXT stock?

Our analysis rates BWX Technologies Inc's overall risk as Conservative. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of BWXT?

BWX Technologies Inc currently has a price-to-earnings (P/E) ratio of 51.9. This is above the market average, suggesting the stock may be priced for high growth expectations.

Does BWX Technologies Inc pay a dividend?

Yes, BWX Technologies Inc pays a dividend with a current yield of approximately 0.56%.

Is BWX Technologies Inc's revenue growing?

BWX Technologies Inc has reported revenue growth of 21.4%. The company is showing strong top-line momentum.

Is BWXT stock profitable?

BWX Technologies Inc has a profit margin of 10.2%. The company is profitable but margins are modest.

How often is the BWXT DVR analysis updated?

Our AI-powered analysis of BWX Technologies Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on June 16, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for BWXT (BWX Technologies Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to BWXT Stock Risk & Deep Value Analysis